This suggests that overexpressed lncRNA BC087858 might be functionally involved in the TKI-gefitinib acquired resistance mechanisms through a dysfunctional activation of the PI3K/AKT, MEK/ERK cell signaling pathways, and EMT process in lung cancer [82]. The gene discussed is PIK3CA; the disease is lung carcinoma.